Show simple item record

dc.contributor.authorYokoyama, M
dc.contributor.authorStevens, E
dc.contributor.authorLaabei, M
dc.contributor.authorBacon, L
dc.contributor.authorHeesom, K
dc.contributor.authorBayliss, S
dc.contributor.authorOoi, N
dc.contributor.authorO'Neill, AJ
dc.contributor.authorMurray, E
dc.contributor.authorWilliams, P
dc.contributor.authorLubben, A
dc.contributor.authorReeksting, S
dc.contributor.authorMeric, G
dc.contributor.authorPascoe, B
dc.contributor.authorSheppard, SK
dc.contributor.authorRecker, M
dc.contributor.authorHurst, LD
dc.contributor.authorMassey, RC
dc.date.accessioned2018-08-31T13:22:51Z
dc.date.issued2018-07-18
dc.description.abstractBACKGROUND: Fitness costs imposed on bacteria by antibiotic resistance mechanisms are believed to hamper their dissemination. The scale of these costs is highly variable. Some, including resistance of Staphylococcus aureus to the clinically important antibiotic mupirocin, have been reported as being cost-free, which suggests that there are few barriers preventing their global spread. However, this is not supported by surveillance data in healthy communities, which indicate that this resistance mechanism is relatively unsuccessful. RESULTS: Epistasis analysis on two collections of MRSA provides an explanation for this discord, where the mupirocin resistance-conferring mutation of the ileS gene appears to affect the levels of toxins produced by S. aureus when combined with specific polymorphisms at other loci. Proteomic analysis demonstrates that the activity of the secretory apparatus of the PSM family of toxins is affected by mupirocin resistance. As an energetically costly activity, this reduction in toxicity masks the fitness costs associated with this resistance mutation, a cost that becomes apparent when toxin production becomes necessary. This hidden fitness cost provides a likely explanation for why this mupirocin-resistance mechanism is not more prevalent, given the widespread use of this antibiotic. CONCLUSIONS: With dwindling pools of antibiotics available for use, information on the fitness consequences of the acquisition of resistance may need to be considered when designing antibiotic prescribing policies. However, this study suggests there are levels of depth that we do not understand, and that holistic, surveillance and functional genomics approaches are required to gain this crucial information.en_GB
dc.description.sponsorshipMY is a self-funded PhD student and ES is on a BBSRC DTP PhD training program.en_GB
dc.identifier.citationVol. 19, article 94en_GB
dc.identifier.doi10.1186/s13059-018-1469-2
dc.identifier.urihttp://hdl.handle.net/10871/33867
dc.language.isoenen_GB
dc.publisherBioMed Centralen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/30021593en_GB
dc.rights© The Author(s) 2018. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_GB
dc.subjectEpistasisen_GB
dc.subjectFitness costsen_GB
dc.subjectGWASen_GB
dc.subjectMRSAen_GB
dc.subjectMupirocin resistanceen_GB
dc.titleEpistasis analysis uncovers hidden antibiotic resistance-associated fitness costs hampering the evolution of MRSAen_GB
dc.typeArticleen_GB
dc.date.available2018-08-31T13:22:51Z
exeter.place-of-publicationEnglanden_GB
dc.descriptionThis is the final version of the article. Available from BioMed Central via the DOI in this record.en_GB
dc.identifier.journalGenome Biologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record